Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of July 8, 2026, GKOS trades at $150.59 with a market cap of $8.73B and a P/E ratio of -45.59. GKOS moved +1.31% today. Year to date, GKOS is +31.87%; over the trailing twelve months it is +48.48%. Its 52-week range spans $73.16 to $163.71. Analyst consensus is strong buy with an average price target of $158.33. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Glaukos Corporation (GKOS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GKOS moved +1.31% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $150.59 |
| Market Cap | $8.73B |
| P/E Ratio | -45.59 |
| EPS | $-3.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $163.71 |
| 52-Week Low | $73.16 |
| Volume | 497.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $507.44M |
| Net Income | $-187.69M |
| Gross Margin | 55.72% |
12 analysts cover GKOS: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $158.33.